全文获取类型
收费全文 | 10537篇 |
免费 | 901篇 |
国内免费 | 320篇 |
专业分类
耳鼻咽喉 | 87篇 |
儿科学 | 279篇 |
妇产科学 | 167篇 |
基础医学 | 773篇 |
口腔科学 | 210篇 |
临床医学 | 1164篇 |
内科学 | 1347篇 |
皮肤病学 | 179篇 |
神经病学 | 257篇 |
特种医学 | 277篇 |
外国民族医学 | 4篇 |
外科学 | 1063篇 |
综合类 | 2066篇 |
现状与发展 | 1篇 |
预防医学 | 1080篇 |
眼科学 | 190篇 |
药学 | 1264篇 |
13篇 | |
中国医学 | 766篇 |
肿瘤学 | 571篇 |
出版年
2024年 | 46篇 |
2023年 | 110篇 |
2022年 | 292篇 |
2021年 | 424篇 |
2020年 | 354篇 |
2019年 | 223篇 |
2018年 | 258篇 |
2017年 | 302篇 |
2016年 | 230篇 |
2015年 | 413篇 |
2014年 | 482篇 |
2013年 | 705篇 |
2012年 | 984篇 |
2011年 | 934篇 |
2010年 | 757篇 |
2009年 | 731篇 |
2008年 | 721篇 |
2007年 | 674篇 |
2006年 | 627篇 |
2005年 | 567篇 |
2004年 | 409篇 |
2003年 | 289篇 |
2002年 | 231篇 |
2001年 | 170篇 |
2000年 | 146篇 |
1999年 | 76篇 |
1998年 | 37篇 |
1997年 | 28篇 |
1996年 | 39篇 |
1995年 | 37篇 |
1994年 | 33篇 |
1993年 | 36篇 |
1992年 | 28篇 |
1991年 | 31篇 |
1990年 | 37篇 |
1989年 | 25篇 |
1988年 | 25篇 |
1987年 | 32篇 |
1986年 | 17篇 |
1985年 | 22篇 |
1984年 | 13篇 |
1983年 | 15篇 |
1982年 | 12篇 |
1980年 | 15篇 |
1979年 | 16篇 |
1978年 | 12篇 |
1977年 | 10篇 |
1975年 | 8篇 |
1974年 | 8篇 |
1973年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的 探讨不同非密闭雾化方式在不合作患儿接受布地奈德雾化治疗中的应用效果。方法 选取本院门诊270例3岁以下使用布地奈德雾化治疗的患儿,采用随机数字表法将患儿分为Pari雾化系统、Philips雾化系统及Salter雾化系统3个治疗组,毎组90例,各组又依据面罩距离面部0 cm、2 cm、4 cm分为3个小组,毎组30例,分别测量各组雾化气流流速及吸入雾化颗粒量占总雾化颗粒量的比例。采用方差分析及Bonferroni进行统计分析。结果 雾化气流流速及雾化吸入量在不同雾化系统组间差异有统计学意义(P<0.05)。在3种距离下,Pari系统均能使患儿吸入最多量的雾化颗粒,其次是Salter系统,再是Philips系统,与此相反,气流流速Pari系统最低。Pari系统离开面部4 cm及Salter系统离开面部2 cm的吸入量均高于Philips系统0 cm的吸入量。结论 选择合适的非密闭雾化系统方式,是提高不合作患儿布地奈德雾化治疗的有效方式。 相似文献
2.
4.
5.
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease
Abhinav Sharma Adrian Coles Nishant K. Sekaran Neha J. Pagidipati Michael T. Lu Daniel B. Mark Kerry L. Lee Hussein R. Al-Khalidi Udo Hoffmann Pamela S. Douglas 《Journal of the American College of Cardiology》2019,73(8):893-902
Background
The optimal noninvasive test (NIT) for patients with diabetes and stable symptoms of coronary artery disease (CAD) is unknown.Objectives
The purpose of this study was to assess whether a diagnostic strategy based on coronary computed tomographic angiography (CTA) is superior to functional stress testing in reducing adverse cardiovascular (CV) outcomes (CV death or myocardial infarction [MI]) among symptomatic patients with diabetes.Methods
PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) was a randomized trial evaluating an initial strategy of CTA versus functional testing in stable outpatients with symptoms suggestive of CAD. The study compared CV outcomes in patients with diabetes (n = 1,908 [21%]) and without diabetes (n = 7,058 [79%]) based on their randomization to CTA or functional testing.Results
Patients with diabetes (vs. without) were similar in age (median 61 years vs. 60 years) and sex (female 54% vs. 52%) but had a greater burden of CV comorbidities. Patients with diabetes who underwent CTA had a lower risk of CV death/MI compared with functional stress testing (CTA: 1.1% [10 of 936] vs. stress testing: 2.6% [25 of 972]; adjusted hazard ratio: 0.38; 95% confidence interval: 0.18 to 0.79; p = 0.01). There was no significant difference in nondiabetic patients (CTA: 1.4% [50 of 3,564] vs. stress testing: 1.3% [45 of 3,494]; adjusted hazard ratio: 1.03; 95% confidence interval: 0.69 to 1.54; p = 0.887; interaction term for diabetes p value = 0.02).Conclusions
In diabetic patients presenting with stable chest pain, a CTA strategy resulted in fewer adverse CV outcomes than a functional testing strategy. CTA may be considered as the initial diagnostic strategy in this subgroup. (PROspective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550) 相似文献6.
Amos Adler Na'ama Sturlesi Noga Fallach Deniz Zilberman-Barzilai Omar Hussein Shlomo E. Blum Eyal Klement Mitchell J. Schwaber Yehuda Carmeli 《Journal of clinical microbiology》2015,53(11):3515-3521
Our objectives were to study the prevalence, risk factors for carriage, and transmission dynamics of extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae (ESBLPE) in a national survey of cattle. This was a point prevalence study conducted from July to October 2013 in Israel. Stool samples were collected from 1,226 cows in 123 sections on 40 farms of all production types. ESBLPE were identified in 291 samples (23.7%): 287 contained Escherichia coli and 4 contained Klebsiella pneumoniae. The number of ESBLPE-positive cows was the highest in quarantine stations and on fattening farms and was the lowest on pasture farms (P = 0.03). The number of ESBLPE-positive cows was the lowest in sections containing adult cows (age, >25 months) and highest in sections containing calves (age, <4 months) (P < 0.001). Infrastructure variables that were significant risk factors for ESBLPE carriage included crowding, a lack of manure cleaning, and a lack of a cooling (P < 0.001 for each), all of which were more common in sections containing calves. Antimicrobial prophylaxis was given almost exclusively to calves and was associated with a high number of ESBLPE carriers (P < 0.001). The 287 E. coli isolates were typed into 106 repetitive extragenic palindromic (REP)-PCR types and mostly harbored blaCTX-M-1 or blaCTX-M-9 group genes. The isolates on the six farms with ≥15 isolates of ESBLPE were of 4 to 7 different REP-PCR types, with one dominant type being harbored by about half of the isolates. Fourteen types were identified on more than one farm, with only six of the farms being adjacent to each other. The prevalence of ESBLPE carriage is high in calves in cowsheds where the use of antimicrobial prophylaxis is common. ESBLPE disseminate within cowsheds mainly by clonal spread, with limited intercowshed transmission occurring. 相似文献
7.
背景与目的:恶性肿瘤是全球重大的公共健康问题,患者生存率是评价恶性肿瘤诊治水平的重要指标。通过描述以医院登记为基础的20万例恶性肿瘤患者的生存情况,以真实世界数据从一个侧面反映我国恶性肿瘤的治疗效果。方法:纳入2008年1月1日—2017年12月31日之间在复旦大学附属肿瘤医院确诊为恶性肿瘤并接受住院治疗的患者共计202 542例。通过患者复诊病史资料、电话随访及死因数据链接等方式收集生存随访信息,随访统计时间截至2019年11月30日。应用寿命表法估计各个病种1年、3年和5年总生存率(overall survival,OS),以性别、年龄组、首次治疗时间分层。采用Kaplan-Meier生存曲线绘制各病种的总体生存曲线。结果:患者总体的1年、3年、5年OS分别为89.8%、77.4%和71.0%;男性患者5年OS为58.8%,女性患者为78.7%。在常见的恶性肿瘤中,甲状腺癌患者的5年OS最高,为98.6%;胰腺癌患者最低,为11.4%。2013—2017年首次治疗的乳腺癌、肺癌和肾癌患者5年OS分别为90.0%、55.9%和80.7%,显著高于2008—2012年首次治疗患者,其他肿瘤未见显著上升。结论:大部分恶性肿瘤患者经规范诊治可以获得较为理想的预后,女性生存情况显著优于男性,乳腺癌和肺癌患者的生存改善可能归功于新的临床治疗和早诊手段。 相似文献
8.
9.
10.